Sports Medicine

, Volume 29, Issue 2, pp 113–133 | Cite as

Evaluation of the Ergogenic Properties of Ginseng

An Update
Review Article


Ginseng has been used in the Orient for several thousand years as an ‘adaptogenic’ as well as a ‘restorative’ agent. It has been used to treat nervous disorders, anaemia, wakefulness, dyspnoea, forgetfulness and confusion, prolonged thirst, decreased libido, chronic fatigue, angina and nausea. Although the mechanisms underlying the alleged effects of ginseng remain to be elucidated, there is an extensive animal literature dealing with the effects of ginseng on the cardiovascular system, central nervous system, endocrine system, metabolism, and immune system. In our previous review dealing with the efficacy of ginseng, we concluded that while studies with animals show that ginseng, or its active components, may prolong survival to physical or chemical stress, there is generally a lack of controlled research demonstrating the ability of ginseng to improve or prolong performance in fatigued humans. In this review, we extend our earlier analysis on the potential efficacy of ginseng use in the enhancement of physical performance and modification of fatigue states. Our analysis reveals that published literature appearing since our earlier review has not resolved the equivocal nature of research evidence involving animals or humans. Also, the lack of unanimity in this research can be explained on the basis of various methodological problems such as inadequate sample size and lack of double-blind, control and placebo paradigms. In addition, the absence of acceptable approaches to the problem of ‘sourcing’, in concert with an absence of compliance data in human research, further complicates the interpretation of this research literature. Nevertheless, the use of ginseng continues to grow, and current sales are estimated to be over $US300 million annually. There is clearly a need for systematic research dealing with the efficacy of ginseng, and this research needs to take into account basic, fundamental design considerations if there is to be any hope of establishing whether or not ginseng possesses efficacy.


  1. 1.
    Horowitz B. Tea maker’s herbal addition: firm trying to supplement sales. USA Today 1998 April 14; 4BGoogle Scholar
  2. 2.
    Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273 (8): 607–9PubMedGoogle Scholar
  3. 3.
    Miller LG. Herbal medicinals. Arch Intern Med 1998; 158 (20): 2200–11PubMedGoogle Scholar
  4. 4.
    Richman A, Witkowski J. Herbs by the numbers. Whole Foods Magazine 1997; 20, 22, 24, 26, 28Google Scholar
  5. 5.
    Hellmich N. Herbal remedies take root, flourish. USA Today 1998 Dec 29; 6DGoogle Scholar
  6. 6.
    Deveny K. Garlic pills are potent drugstore sellers. Wall Street J 1992 Oct 1; B1, B14Google Scholar
  7. 7.
    Goldstein B. Ginseng: its history, dispersion, and folk tradition. Am J Chin Med 1975; 3 (3): 223–34PubMedGoogle Scholar
  8. 8.
    Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med 1977; 5 (1): 1–23PubMedGoogle Scholar
  9. 9.
    Liu C-X, Xiao P-G. Recent advances in ginseng research in China. J Ethnopharmacol 1992; 36: 27–38PubMedGoogle Scholar
  10. 10.
    Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969; 9: 419–30PubMedGoogle Scholar
  11. 11.
    Cartwright L. Ginseng in pharmacies. Aust J Pharm 1979; 60: 346–9Google Scholar
  12. 12.
    Hu SY. The genus Panax (ginseng) in Chinese medicine. Econ Botany 1976; 30: 11–28Google Scholar
  13. 13.
    Li CP, Li RC. An introductory note to ginseng. Am J Chin Med 1973; 1 (2): 249–61PubMedGoogle Scholar
  14. 14.
    Perry LM, Metzger J. Medicinal plants of east and southeast asia: attributed properties and uses. Cambridge (MA): MIT Press, 1980Google Scholar
  15. 15.
    Baranov A. Recent advances in our knowledge of the morphology, cultivation and uses of ginseng (Panax ginseng C.A. Meyer). Econ Botany 1966; 20: 403–6Google Scholar
  16. 16.
    Bittles AH, Fulder SJ, Grant EC, et al. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979; 25: 125–31PubMedGoogle Scholar
  17. 17.
    Popov IM, Goldwag WJ. A review of the properties and clinical effects of ginseng. Am J Chin Med 1973; 1 (2): 263–70PubMedGoogle Scholar
  18. 18.
    Phillipson JD, Anderson LA. Ginseng: quality, safety, and efficacy? Pharm J 1984; 232: 161–5Google Scholar
  19. 19.
    Bahrke MS, Morgan WP. Evaluation of the ergogenic properties of ginseng. Sports Med 1994; 18 (4): 229–48PubMedGoogle Scholar
  20. 20.
    Pietta P, Mauri P, Rava A. Improved high-performance liquid chromatographic method for the analysis of ginsenosides in Panax ginseng extracts and products. J Chromatogr 1986; 356: 212–9PubMedGoogle Scholar
  21. 21.
    Barna P. Food or drug? The case of ginseng [letter]. Lancet 1985; II: 548Google Scholar
  22. 22.
    Court WE. Ginseng: a Chinese folk medicine of current interest. Pharm J 1975; 214: 180–1Google Scholar
  23. 23.
    Williams LO. Ginseng. Econ Botany 1957; 11: 344–8Google Scholar
  24. 24.
    Baranov AI. Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. J Ethnopharmacol 1982; 6: 339–53PubMedGoogle Scholar
  25. 25.
    Brekhman II. Eleutherococcus senticosus: a new medicinal herb of the araliaceae family. In: Chen KK, Mukerji B, editors. Pharmacology of oriental plants. New York (NY):Macmillan Company, 1965: 97–102Google Scholar
  26. 26.
    Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci 1978; 67 (10): 1487–9PubMedGoogle Scholar
  27. 27.
    Hou JP. The chemical constituents of ginseng plants. Comp Med East West 1977; 5 (2): 123–45PubMedGoogle Scholar
  28. 28.
    Iwabuchi H, Yoshikura M, Ikawa Y, et al. Studies on the sesquiterpenoids of Panax ginseng C.A.Meyer: isolation and structure determination of sesquiterpene alcohols, panasinsanols A and B. Chem Pharm Bull 1987; 35 (5): 1975–81PubMedGoogle Scholar
  29. 29.
    Iwabuchi H, Yoshikura M, KamisakoW. Studies on the sesquiterpenoids of Panax ginseng C.A. Meyer II: isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. Chem Pharm Bull 1988; 36 (7): 2447–51PubMedGoogle Scholar
  30. 30.
    Kasai R, Yamaguchi H, Tanaka O. High-performance liquid chromatography of glycosides on a new type of hydroxyapatite column. J Chromatogr 1987; 407: 205–10PubMedGoogle Scholar
  31. 31.
    Shibata S, Fujita M, Itokawa H, et al. Studies on the constituents of Japanese and Chinese crude drugs: XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull 1963; 11 (6): 759–61PubMedGoogle Scholar
  32. 32.
    Tanaka O, Nagai M, Shibata S. Chemical studies on the Oriental plant drugs: XVI. The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem Pharm Bull 1966; 14 (10): 1150–6PubMedGoogle Scholar
  33. 33.
    Yamaguchi H, Kasai R, Matsuura H, et al. High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 1988; 36 (9): 3468–73PubMedGoogle Scholar
  34. 34.
    Iida Y, Tanaka O, Shibata S. Studies on saponins of ginseng: the structure of ginsenoside-Rg1. Tetrahedron Lett 1968; 52: 5449–53Google Scholar
  35. 35.
    Shibata S, Tanaka O, Soma K, et al. Studies on saponins and sapogenins of ginseng: the structure of panaxatriol. Tetrahedron Lett 1965; 3: 207–13Google Scholar
  36. 36.
    Besso H, Kasai R, Wei J, et al. Further studies on dammaranesaponins of American ginseng, roots of Panax quinquefolium L. Chem Pharm Bull 1982; 30 (12): 4534–8Google Scholar
  37. 37.
    Elyakov GB, Strigina LI, Uvarova NI, et al. Glycosides from ginseng roots. Tetrahedron Lett 1964; 48: 3591–7Google Scholar
  38. 38.
    Petkov VD, Yinglin C, Todorov I, et al. Behavioral effects of stem-leaves extract from Panax ginseng C.A. Meyer. Acta Physiol Pharmacol Bulg 1992; 18 (2): 41–8PubMedGoogle Scholar
  39. 39.
    Chong SKF, Oberholzer VG. Ginseng: is there a use in clinical medicine? Postgrad Med J 1988; 64: 841–6PubMedGoogle Scholar
  40. 40.
    Matsuda H, Namba K, Fukuda S, et al. Pharmacological study on Panax ginseng C.A. Meyer: III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems. Chem Pharm Bull 1986; 34 (3): 1153–7PubMedGoogle Scholar
  41. 41.
    Mattei R, Dias RF, Espinola EB, et al. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro. J Ethnopharmacol 1998; 60 (2): 111–6PubMedGoogle Scholar
  42. 42.
    Wang LCH, Lee T-F. Effect of ginseng saponins on exercise performance in non-trained rats. Planta Med 1998; 64: 130–3PubMedGoogle Scholar
  43. 43.
    Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and ginseng. J Ethnopharmacol 1994; 44 (3): 131–5PubMedGoogle Scholar
  44. 44.
    Nitta H, Matsumoto K, Shimizu M, et al. Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task. Biol Pharm Bull 1995; 18 (9): 1286–8PubMedGoogle Scholar
  45. 45.
    Huong NTT, Matsumoto K, Yamasaki K, et al. Crude saponin extracted from Vietnamese ginseng and its major constituent majonoside-R2 attenuate the psychological stress- and foot-shock stress-induced antinociception in mice. Pharmacol Biochem Behav 1995; 52 (2): 427–32Google Scholar
  46. 46.
    Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res 1996; 57 (12): 959–68Google Scholar
  47. 47.
    Wesnes KA, Faleni RA, Hefting NR, et al. The cognitive, subjective, and physical effects of a Ginko biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol Bull 1997; 33 (4): 677–83PubMedGoogle Scholar
  48. 48.
    Thommessen B, Laake K. Ginseng: no identifiable effect in geriatric rehabilitation. Tidsskr Nor Laegeforen 1997; 117 (26): 3839–41PubMedGoogle Scholar
  49. 49.
    Smith K, Engels H-J, Martin J, et al. Efficacy of a standardized ginseng extract to alter psychological function characteristics at rest and during exercise stress [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147Google Scholar
  50. 50.
    Marasco A, Ruiz R, Villagomez A, et al. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996; 22 (6): 323–9Google Scholar
  51. 51.
    Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18 (10): 1373–5PubMedGoogle Scholar
  52. 52.
    Han KH, Choe SC, Kim HS, et al. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998; 26 (2): 199–209PubMedGoogle Scholar
  53. 53.
    Macaraeg PVJ, Ramos E. The effect of ginseng on exercise duration [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 151Google Scholar
  54. 54.
    Ng CC, Ng YK. The effect of ginseng: a traditional Chinese medicine on physical capacity [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 196Google Scholar
  55. 55.
    McNaughton L, Egan G, Caelli G. A comparison of Chinese and Russian ginseng as ergogenic aids to improve various facets of physical fitness. Int Clin Nutr Rev 1989; 9 (1): 32–5Google Scholar
  56. 56.
    Gribaudo CG, Ganzit GP, Verzini EF. Effetti sulla forza e sulla fatica muscolare di un prodotto ergogenico di origine naturale. Med Dello Sport 1990; 43 (4): 241–9Google Scholar
  57. 57.
    Gribaudo CG, Ganzit GP, Biancotti PP, et al. Effetti della somministrazione di un prodotto naturale ergogenico sulle doti aerobiche di ciclisti agonisti. Med Dello Sport 1991; 44 (4): 335–43Google Scholar
  58. 58.
    Morris AC, Jacobs I, McLellan TM, et al. No ergogenic effect of ginseng ingestion. Int J Sport Nutr 1996; 6: 263–71PubMedGoogle Scholar
  59. 59.
    Lifton B, Otto RM, Wygand J. The effect of ginseng on acute maximal aerobic exercise [abstract]. Med Sci Sports Exerc 1997; 29 (5) Suppl.: S249Google Scholar
  60. 60.
    Allen JD, McLung J, Nelson AG, et al. Ginseng supplementation does not enhance healthy young adults’ peak aerobic exercise performance. J Am Coll Nutr 1998; 17 (5): 462–6PubMedGoogle Scholar
  61. 61.
    Engels H-J, Said JM, Wirth JC. Failure of chronic ginseng supplementation to affect work performance and energy metabolism in healthy adult females. Nutr Res 1996; 16 (8): 1295–305Google Scholar
  62. 62.
    Engels H-J, Said J, Wirth JC, et al. Effect of chronic ginseng intake on metabolic responses during and in the recovery from graded maximal exercise [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147Google Scholar
  63. 63.
    Engels H-J, Feng S, Chen Y. Effect of ginseng (G115) on maximal aerobic exercise performance in aerobically fit young adults [abstract]. The XXVI FIMS World Congress of Sports Medicine Abstracts 1998; Champaign (IL): Fédération Internationale de Médicine Sportive, 1998: 33Google Scholar
  64. 64.
    Engels H-J, Wirth JC. No ergogenic effects of ginseng (Panax Ginseng C.A. Meyer) during graded maximal aerobic exercise [abstract]. Int J Sport Nutr 1998; 8: 202Google Scholar
  65. 65.
    Kolokouri I, Engels H-J, Cieslak T, et al. Effect of chronic ginseng supplementation on short duration, supramaximal exercise test performance [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117Google Scholar
  66. 66.
    Asano K, Takahashi T, Miyashita M, et al. Effect of Eleutheroccocus senticosus extract on human physical working capacity. Planta Med 1986; 3: 175–7PubMedGoogle Scholar
  67. 67.
    Dowling EA, Redondo DR, Branch JD, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc 1996; 28 (4): 482–9PubMedGoogle Scholar
  68. 68.
    Eschbach LC, Webster MJ, Boyd JC, et al. The effect of Eleutherococcus senticosus (Siberian ginseng) on substrate utilization and performance during prolonged cycling [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117Google Scholar
  69. 69.
    Morgan WP. Methodological considerations. In: Morgan WP, editor. Physical activity and mental health. Washington, DC: Taylor and Francis, 1997: 3–32Google Scholar
  70. 70.
    Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA 1979; 241 (15): 1614–5PubMedGoogle Scholar
  71. 71.
    Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999; 56: 125–38PubMedGoogle Scholar
  72. 72.
    Ryu S-J, Chien Y-Y. Ginseng-associated cerebral arteritis. Neurology 1995; 45: 829–30PubMedGoogle Scholar
  73. 73.
    Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692–3PubMedGoogle Scholar
  74. 74.
    Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neurol Ophthalmol 1994; 14 (1): 9–11Google Scholar
  75. 75.
    Baldwin CA, Anderson LA, Phillipson JD. What pharmacists should know about ginseng. Pharm J 1986; 237: 583–6Google Scholar
  76. 76.
    Owen RT. Ginseng: a pharmacological profile. Drugs Today 1981; 17: 343–51Google Scholar
  77. 77.
    Johnston BA. One-third of nation’s adults use herbal remedies. Herbalgram 1997; 40: 49Google Scholar
  78. 78.
    Li TSC, Mazza G, Cottrell AC, et al. Ginsenosides in roots and leaves of American ginseng. J Agric Food Chem 1996; 44 (3): 717–20Google Scholar
  79. 79.
    Smith RG, Caswell D, Carriere A, et al. Variation in the ginsenoside content of American ginseng, Panax quinquefolius Lroots. Can J Bot 1996; 74: 1616–20Google Scholar
  80. 80.
    Vigano C, Ceppi E. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619PubMedGoogle Scholar
  81. 81.
    Walker AF. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619PubMedGoogle Scholar
  82. 82.
    Awang DVC. Siberian ginseng toxicity may be case of mistaken identity [letter]. Can Med J 1996; 155 (9): 1237Google Scholar
  83. 83.
    Bahrke MS. Ginseng: a root just like a carrot [letter]. J R Soc Med 1995; 88: 304PubMedGoogle Scholar
  84. 84.
    Bahrke MS. Comments on ‘Manic episode and ginseng: report of a possible case’ [letter]. J Clin Psychopharmacol 1997; 17 (2): 140–1PubMedGoogle Scholar
  85. 85.
    Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance [letter]. JAMA 1996; 276 (8): 606–7PubMedGoogle Scholar
  86. 86.
    Chosidow O, Dega H, Peytavin G. Authors’ reply [letter]. Lancet 1996; 348: 267Google Scholar
  87. 87.
    Dega H, Laporte J-L, Frances C, et al. Ginseng as a cause for Stevens-Johnson syndrome [letter]? Lancet 1996; 347: 1344PubMedGoogle Scholar
  88. 88.
    Faleni R, Soldati F. Ginseng as cause of Stevens-Johnson syndrome [letter]? Lancet 1996; 348: 267PubMedGoogle Scholar
  89. 89.
    Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case [letter]. J Clin Psychopharmacol 1995; 15 (6): 447–8PubMedGoogle Scholar
  90. 90.
    Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992; 117: 165–6PubMedGoogle Scholar
  91. 91.
    Hammond TG, Whitworth JA. Adverse reactions to ginseng [letter]. Med J Aust 1981 May 2; 492Google Scholar
  92. 92.
    McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155 (3): 293–5Google Scholar
  93. 93.
    Wilkie A, Cordes C. Ginseng: a root just like a carrot [letter]? J R Soc Med 1994; 87 (10): 594–5PubMedGoogle Scholar
  94. 94.
    Cui J-F. Identification and quantification of ginsenosides in various commercial ginseng preparations. Euro J Pharm Sci 1995; 3 (2): 77–85Google Scholar
  95. 95.
    Cui J-F, Garle M, Bjokhem I, et al. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Scand J Clin Lab Invest 1996; 56: 151–60PubMedGoogle Scholar
  96. 96.
    Vaughan MA, Doolittle RL, Gennett T, et al. Physiological effects of ginseng may be due to methylxanthines [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S121Google Scholar
  97. 97.
    Matsunaga H, Katano M, Yamamoto H, et al. Cytotoxic activity of polyacetylene compounds in Panax ginseng C.A. Meyer. Chem Pharm Bull 1990; 38: 3480–2PubMedGoogle Scholar
  98. 98.
    Madison WI. Officials question purity of ginseng: regulators find use of illegal pesticides. Capital Times 1997 Oct 7Google Scholar
  99. 99.
    Cable News Network. Company says ginseng batch contaminated [online]. Available from: [Accessed 1999 Dec 15]
  100. 100.
    Ginseng warning. USA Today 1997 Dec 19; 3AGoogle Scholar
  101. 101.
    Watt J, Bottomly MB, Read MTF. Olympic athletics medical experience. Seoul: personal views. Br J Sports Med 1989; 23 (2): 76–9PubMedGoogle Scholar
  102. 102.
    Fuentes RJ, Rosenberg JM, Davis A, editors. Athletic drug reference. Durham (NC): Clean Data Inc., 1996Google Scholar
  103. 103.
    Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997; 54 (1): 1–8PubMedGoogle Scholar
  104. 104.
    Trine MR. Physical activity and quality of life. In: Rippe JM, editor. Lifestyle medicine. Malden (MA): Blackwell Scientific Publications, 1999: 989–99Google Scholar
  105. 105.
    Wiklund I, Karlberg J, Lund B. A double-blind comparison of the effect on quality of life of a combination of vital substances including standardized ginseng G115 and placebo. Curr Ther Res 1994; 55 (1): 32–42Google Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  1. 1.Human KineticsChampaignUSA
  2. 2.Department of KinesiologyUniversity of Wisconsin-MadisonMadisonUSA

Personalised recommendations